bio-crispr-screens-bagel-essentiality

name	bio-crispr-screens-bagel-essentiality
description	Identifies essential genes from CRISPR-Cas9 fitness screens using BAGEL2 (Kim & Hart 2021 Genome Med), a Bayesian classifier scoring per-gene Bayes Factors via log-likelihood ratios over per-sgRNA fold changes, calibrated against CEGv2 core-essentials (Hart 2017 G3, ~684 genes) and NEGv1 non-essentials (Hart 2014, ~927 genes). Covers the fc + bf + pr workflow, the linear-extrapolation improvement over BAGEL1 truncation, multi-target off-target correction, tumor-suppressor sensitivity (BAGEL2 detects enrichment), and BF calibration (BF >6 ≈ 90% posterior per Hart 2017; ~5% FDR by BAGEL convention). Use when classifying essential vs non-essential genes, calibrating BAGEL2 thresholds against PR curves, identifying tumor suppressors alongside essentials, comparing BAGEL2 hits to MAGeCK / drugZ, or generating publication-quality essentiality calls.
origin	openai4s
category	bioskills/crispr-screens
metadata	{"tool_type":"cli","primary_tool":"BAGEL2","third_party":{"name":"GPTomics/bioSkills","repository":"https://github.com/GPTomics/bioSkills","commit":"d91ed3d563019e649dc854c56ccd62551359488a","license":"MIT"}}

Version Compatibility

Reference examples tested with: BAGEL2 2.0 (hart-lab/bagel, build 115), pandas 2.2+, numpy 1.26+, scipy 1.12+, matplotlib 3.8+.

Before using code patterns, verify installed versions match. If versions differ:

• CLI: BAGEL.py fc --help; BAGEL.py bf --help; BAGEL.py pr --help
• Python: BAGEL2 is distributed via git clone (no canonical PyPI release); confirm BAGEL.py version after checkout.

If code throws ImportError, AttributeError, or TypeError, introspect the installed package and adapt the example to match the actual API rather than retrying.

BAGEL2 Essentiality Analysis

"Identify essential genes from my CRISPR fitness screen using BAGEL2" -> Compute per-sgRNA fold changes from counts, derive per-gene log-likelihood ratios against reference essential and non-essential gene sets, sum to Bayes Factor, and apply BF threshold calibrated by precision-recall against the reference.

• CLI: BAGEL.py fc to compute fold changes
• CLI: BAGEL.py bf to compute Bayes Factors
• CLI: BAGEL.py pr for precision-recall curves
• Reference sets: CEGv2 (essentials) and NEGv1 (non-essentials); both at https://github.com/hart-lab/bagel

The BAGEL2 Bayesian Framework (under the hood)

Why this matters for postdoc-level use: BAGEL2 uses a Bayes-factor classifier trained on known essential and non-essential genes. The chain:

1. For each sgRNA, compute log-fold-change (LFC) treatment vs control.
2. For each gene, look up per-sgRNA LFCs.
3. For each sgRNA, compute the log-likelihood ratio: log( P(LFC | gene is essential) / P(LFC | gene is non-essential) ). The numerator and denominator are KDEs (kernel density estimates) of LFC distributions from CEGv2 and NEGv1 reference sgRNAs.
4. Sum per-gene log-likelihood ratios across all sgRNAs targeting the gene -> per-gene Bayes Factor.
5. Resampling for the confidence interval (default: 10-fold cross-validation; -b switches to bootstrapping with -NB, default 1000); BF >6 corresponds to ~90% posterior probability (Hart 2017 G3); ~5% FDR by BAGEL convention.

Critical BAGEL2 improvements over BAGEL1:

• Linear extrapolation: BAGEL1 truncated the LLR at the edges of its KDE; BAGEL2 fits a linear regression in the stable region and extrapolates, giving wider dynamic range. This recovers tumor suppressors (highly positive LFC) that BAGEL1 missed.
• Multi-target correction: For sgRNAs targeting multiple genomic loci (off-targets), BAGEL2 discards them and regresses out their BF contribution, but only when -m/--filter-multi-target is given together with --align-info. The original BAGEL counted off-target hits as essentiality signal.
• Tumor suppressor sensitivity: BAGEL2 correctly identifies positive selection (enrichment) genes -- not possible in BAGEL1.

Calibration to CEGv2 / NEGv1

Why these reference sets matter: BAGEL2's discriminative power depends on KDEs of LFCs from known essential vs known non-essential genes. CEGv2 (Hart 2017) is 684 core essential genes shared across cell lines; NEGv1 (Hart 2014) is 927 non-essential genes verified across multiple screens. These act as positive and negative controls within every screen.

Reference set integrity:

• CEGv2: pan-cancer essentials -- common dropouts across most cancer cell lines
• NEGv1: confidently non-essential -- genes without expression or genes with verified neutral status

Critical pitfall: Using a custom essentiality reference (e.g., a single-cell-line CRISPR screen) instead of CEGv2 biases the BAGEL2 model toward that line's specific biology. Always use the standardized references unless there is a specific reason for custom training.

Compute Per-Sample Fold Changes

Goal: Generate per-sgRNA fold-change matrix as input for Bayes-factor calculation.

Approach: Take normalized counts, compute log-fold-change vs a control (Day 0 or plasmid baseline) per sgRNA.

# BAGEL2 installation: distributed via git clone (no canonical PyPI release).
git clone https://github.com/hart-lab/bagel
cd bagel

# Inputs:
# counts.txt: tab-separated with columns: sgRNA, GENE, Sample1, Sample2, ...
# Control column(s): typically Day 0 or plasmid sample(s)
# Treatment column(s): screen endpoint

BAGEL.py fc \
    -i counts.txt \
    -o foldchange \                        # NOTE: -o is a LABEL for fc; writes foldchange.foldchange
    -c Plasmid \                           # control sample (or Day 0)
    --min-reads 30                         # default is 0; 30 is a common convention
# Output: foldchange.foldchange (per-sgRNA LFCs) and foldchange.normed_readcount

Compute Bayes Factors

Goal: Score per-gene essentiality as a Bayes Factor.

Approach: Run BAGEL.py bf with the fold-change matrix and reference gene sets. Resampling defaults to 10-fold cross-validation; add -b -NB N to bootstrap instead.

BAGEL.py bf \
    -i foldchange.foldchange \
    -o bayes_factor.txt \
    -e CEGv2.txt \                         # essentials reference (CEGv2)
    -n NEGv1.txt \                          # non-essentials reference
    -c Sample1,Sample2,Sample3 \            # treatment samples to score
    -b -NB 1000                            # opt into bootstrapping (default is 10-fold cross-validation)
# Output: bayes_factor.txt - per-gene Bayes Factor + CI

Output columns:

Column	Meaning
GENE	Gene symbol
BF	Per-gene Bayes Factor (log-likelihood ratio summed across sgRNAs)
STD	Standard deviation across the 10 cross-validation folds (or bootstrap iterations with -b)
NumObs	Number of sgRNAs contributing

Interpretation rule: BF >6 corresponds to ~90% posterior probability of essentiality against CEGv2 (Hart 2017; FDR ≤3% in that calibration, with ~5% a looser BAGEL convention); higher BF = stronger evidence the gene is essential. BAGEL2 also reports negative BFs which can indicate tumor suppressors (positive selection).

Precision-Recall Curve

Goal: Empirically select BF threshold for a given precision/recall tradeoff.

Approach: Run BAGEL.py pr to compute precision and recall at every BF level against CEGv2; pick the BF that gives desired precision.

BAGEL.py pr \
    -i bayes_factor.txt \
    -o precision_recall.txt \
    -e CEGv2.txt \
    -n NEGv1.txt
# Output: precision_recall.txt - precision/recall at each BF threshold

Practical BF ladder (regenerate precision and recall per screen with BAGEL.py pr):

BF threshold	Use case
0	Exploratory; highest recall
6	Standard call (~90% posterior, Hart 2017)
12	High-confidence
30	Ultra-stringent; near-certain essentials

Pick threshold based on application: For exploratory hit calling, BF >0 with low precision is acceptable; for clinical-grade essentiality calls, BF >12 or higher.

Interpret BAGEL2 Results

Goal: Stratify genes into essential, non-essential, and tumor-suppressor categories.

Approach: Apply BF threshold to classify; flag negative BF as candidate tumor suppressors.

import pandas as pd

def interpret_bagel(bf_path, bf_essential=6, bf_tumor_suppressor=-6):
    '''Classify genes from BAGEL2 BF output.'''
    df = pd.read_csv(bf_path, sep='\t')
    df['call'] = 'neutral'
    df.loc[df['BF'] > bf_essential, 'call'] = 'essential'
    df.loc[df['BF'] < bf_tumor_suppressor, 'call'] = 'tumor_suppressor'
    return df.sort_values('BF', ascending=False)

Tumor suppressor identification: Genes with significantly negative BF (e.g., <-6) are enriched in the screen, indicating fitness advantage from their loss. This is biologically distinct from "non-essential" and may indicate tumor-suppressor function. BAGEL1 could not detect this; BAGEL2's linear extrapolation enables it.

Bayesian Reasoning Per Sgrna

Why this matters: BAGEL2 computes per-sgRNA contributions; a gene with 4 sgRNAs each contributing +5 to BF gets +20 total. A gene with 3 sgRNAs contributing +5 and 1 sgRNA contributing -3 (off-target or low-efficacy) gets +12 net.

# Per-sgRNA contributions for diagnosis
# Output table: each sgRNA's LLR contribution to gene-level BF
# Useful for identifying low-efficacy guides

Critical: When per-sgRNA contributions are very heterogeneous (one sgRNA dominates BF), the gene is "guide-of-one"; verify with JACKS efficiency analysis or apply the second-best-sgRNA rule from [[hit-calling]].

Comparing BAGEL2, MAGeCK, drugZ

Property	BAGEL2	MAGeCK	drugZ
Statistical framework	Bayes factor with reference sets	NB GLM	Bidirectional Z-score
Calibrated against	CEGv2 / NEGv1	Internal null	Vehicle distribution
Tumor suppressor detection	YES	Limited (RRA positive-selection score)	YES
Best for	Essentiality classification	General hit calling	Chemogenomic drug screens
Output	Bayes factor + CI	FDR + LFC	Z-score + FDR per direction
Hit threshold	BF >6	FDR <0.05	FDR <0.05
Library calibration	Indirect (reference set)	None	None

Reconciliation: BF >6 ≈ 90% posterior probability (Hart 2017 G3); commonly treated as roughly MAGeCK FDR 0.05 by convention. BAGEL2 hits absent from MAGeCK suggest weak signal that BAGEL2's reference anchoring detects but MAGeCK's null-based test misses; verify by inspecting per-sgRNA contributions.

Failure Modes

BAGEL2 returns no hits despite known essentials

Trigger: Wrong reference gene set file; CEGv2 or NEGv1 file may have wrong format or be missing genes. Mechanism: BAGEL2 trains KDEs on the reference; if references are not representative, KDE separation is poor and no gene has BF >6. Symptom: Median BF near zero; no genes >6 even at low FDR. Fix: Re-download CEGv2 / NEGv1 from https://github.com/hart-lab/bagel. Verify gene symbols match the screen's annotation.

BAGEL2 calls negative-LFC genes "tumor suppressors"

Trigger: Heavy dropout screen where many genes drop out; the dropout signal is captured as positive BF but the enriched genes (negative BF) are noise. Mechanism: BAGEL2's symmetric distribution treats deeply enriched genes as significant; in a dropout-only screen, the enrichment signal is purely noise. Symptom: Many genes with negative BF; these don't validate as tumor suppressors. Fix: Restrict tumor-suppressor calling to screens specifically expecting enrichment (e.g., drug-resistance, GoF screens); for dropout screens, only interpret positive BF.

Bootstrap CI is wide; BF estimates unstable

Trigger: Per-gene number of sgRNAs too low (e.g., <4 in some libraries). Mechanism: Bootstrap of LLR over very few sgRNAs creates wide CI. Symptom: STD column larger than BF; many genes have CI spanning zero. Fix: Use a library with at least 4-6 sgRNAs/gene; or switch to bootstrapping (-b -NB 5000); or filter out genes with <3 sgRNAs.

Low BF for known essential despite high LFC

Trigger: One sgRNA per gene is contributing very low LLR (off-target or low-efficacy). Mechanism: BAGEL2 sums LLR; one weak guide drags total down. Symptom: Known essential like RPS3 has BF <6 despite 3 of 4 guides showing -5 LFC. Fix: Inspect per-sgRNA LLR; identify the dragging guide; verify whether to exclude or to use JACKS for efficacy-aware analysis.

Non-cancer cell-line screen with custom essentials

Trigger: Human embryonic kidney HEK293T or iPSC-derived neurons where standard essentials may not be essential. Mechanism: CEGv2 is calibrated for cancer cell lines; some essentials in tumor cells are not essential in iPSC. Symptom: PR curve against CEGv2 shows poor separation; many CEGv2 essentials don't drop out. Fix: Use a cell-type-specific essentialome derived for the relevant lineage; or use MAGeCK / Chronos which doesn't depend on reference sets.

Quantitative Thresholds

Threshold	Value	Source / Rationale
Standard essentiality call	BF >6	Hart 2017: BF>=6 ~ 90% posterior
Stricter essentiality call	BF >12	BAGEL convention; regenerate precision/recall per screen with BAGEL.py pr
Ultra-stringent call	BF >30	BAGEL convention
BF for tumor-suppressor candidate	<-6	Empirical; verify with orthogonal screen
Resampling	10-fold cross-validation (default); -b -NB 1000 to bootstrap	BAGEL2 default
Min reads per sgRNA in control	30	Convention; the BAGEL2 default is 0
Min sgRNAs per gene for stable BF	4-6	Wider with library convention

Common Errors

Error / symptom	Cause	Solution
No hits despite essentials present	Wrong reference set	Re-verify CEGv2 / NEGv1 files
Wide resampling CI	Too few sgRNAs/gene	Increase library coverage; bootstrap with more iterations
Negative BF for known essentials	Confounding factor (e.g., CN amplification)	Pre-correct with CRISPRcleanR / Chronos
Tumor suppressor calls don't validate	Pure dropout screen; enrichment is noise	Restrict tumor suppressor calls to expected design
Per-sgRNA LLR dominated by one guide	Outlier or off-target	Apply second-best-sgRNA rule

References

• Kim E & Hart T. 2021. Genome Medicine 13:2. BAGEL2 algorithm and improvements.
• Hart T & Moffat J. 2016. BMC Bioinformatics 17:164. BAGEL Bayes factor framework.
• Hart T et al. 2017. G3 7:2719. CEGv2 core-essential reference set; BF posterior calibration.
• Hart T et al. 2014. Mol Syst Biol 10:733. Gold-standard essential and non-essential reference sets; source of NEGv1.
• Pacini C et al. 2021. Nat Commun 12:1661. Integrated cross-study dependencies; reference essentiality benchmarks.

Related Skills

• crispr-screens/mageck-analysis - MAGeCK RRA/MLE alternative
• crispr-screens/jacks-analysis - JACKS for per-guide efficacy
• crispr-screens/drugz-chemogenomic - drugZ for drug screens
• crispr-screens/hit-calling - Cross-method decision tree
• crispr-screens/screen-qc - Pre-BAGEL QC including CEGv2 PR-AUC
• crispr-screens/library-design - 4-6 sgRNAs/gene library standard
• crispr-screens/copy-number-correction - Pre-correction for cancer-line screens
• pathway-analysis/go-enrichment - Downstream functional analysis